A detailed history of Teza Capital Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 15,576 shares of CDNA stock, worth $333,637. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,576
Previous 16,639 6.39%
Holding current value
$333,637
Previous $258,000 88.37%
% of portfolio
0.05%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.41 - $33.99 $15,317 - $36,131
-1,063 Reduced 6.39%
15,576 $486,000
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $4,876 - $10,416
-645 Reduced 3.73%
16,639 $258,000
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $7,848 - $12,196
-986 Reduced 5.4%
17,284 $183,000
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $89,523 - $234,952
18,270 New
18,270 $219,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.